3 results match your criteria: "Peking University Institute of Hematology and Peking University People's Hospital[Affiliation]"
Zhonghua Xue Ye Xue Za Zhi
May 2019
Department of Hematology, Shanxi Dayi Hospital, Taiyuan 030032, China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
June 2011
HLA Laboratory, Peking University Institute of Hematology and Peking University People's Hospital, Beijing, 100044 P. R. China.
Objective: To investigate the association of the HLA-DRB1 polymorphism with susceptibility to myelodysplastic syndrome (MDS) and aplastic anemia (AA) in Chinese Han population.
Methods: The polymorphism of HLA-DRB1 alleles in 242 patients with MDS, 115 patients with AA and 2264 umbilical cord blood control samples were tested by polymerase chain reaction-sequence specific primer (PCR-SSP).
Results: Compared with normal controls, the frequency of HLA-DRB1*15 was significantly increased in the MDS group and AA group (22.
Objective: Coherent preemptive therapy criterion was applied in various kinds of allogenic hematopoietic stem-cell transplant (allo-HSCT) recipients with cytomegalovirus (CMV) infection in order to evaluate its clinical value in various kinds of HSCT.
Methods: A total of 318 allo-HSCT patients were monitored for CMV infection. Real-time quantitative polymerase chain reaction (RQ-PCR) was performed to serially monitor CMV viremia after transplantation.